ZOCOR

This brand name is authorized in Australia, Brazil, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Ireland, Italy, Netherlands, Poland, Romania, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug ZOCOR contains one active pharmaceutical ingredient (API):

1 Simvastatin UNII AGG2FN16EV - SIMVASTATIN

Simvastatin has a potent activity in inhibiting HMG-CoA reductase (3-hydroxy–3-ethylglutaryl-CoA-reductase). Simvastatin has been shown to reduce both normal and elevated LDL-C concentrations. Read about Simvastatin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZOCOR Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10AA01	Simvastatin	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2011W, 2012X, 8173E, 9242K, 9243L, 9244M
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525503102110310, 525503103117319, 525503104113317, 525503106116313
Country: CA	Health Products and Food Branch	Identifier(s): 00884332, 00884340, 00884359
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00990468, 01096835, 03750428, 03751480, 09060601, 17582578
Country: EE	Ravimiamet	Identifier(s): 1060715, 1080740, 1163023
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 58845, 58846
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 382531, 454199
Country: FR	Base de données publique des médicaments	Identifier(s): 64607301, 67037301
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 13282, 13283, 13284, 147327, 147329, 182110
Country: HK	Department of Health Drug Office	Identifier(s): 34336, 34337
Country: IE	Health Products Regulatory Authority	Identifier(s): 52092, 52183, 52191, 52241, 52268
Country: IT	Agenzia del Farmaco	Identifier(s): 027216011, 027216023, 027216035, 027216098, 027216100
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 67806, 67814, 67822
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100074640, 100074656, 100081260, 100098800
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68124001, W68124002
Country: SG	Health Sciences Authority	Identifier(s): 03789P, 08893P
Country: US	FDA, National Drug Code	Identifier(s): 0006-0543, 0006-0735, 0006-0740, 0006-0749
Country: ZA	Health Products Regulatory Authority	Identifier(s): 31/7.5/0447, W/7.5/350, W/7.5/351